Trump Expands Tariffs Beyond Supreme Court’s Reach

The president’s tariffs on foreign drugs and furniture rely on national security laws outside the scope of current lawsuits.

News
Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

European companies, a major source of U.S. medicines, are hopeful that their investments and trade deals with the U.S. will spare them from President Trump’s latest tariff barrage.

News
Trump Demands That Drugmakers Lower Some of Their U.S. Prices by September

The administration has not put forward a clear legal authority to compel drugmakers to reduce their prices.

News
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat

The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.

News
Breast Cancer Patients Get Early Warning of Faltering Drugs With Blood Test

A study found that women could switch drugs without waiting for scans showing cancer progression, which improved their quality of life.

News